HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern.

HLA-F is currently the most enigmatic of the human MHC-encoded class Ib genes. We have investigated the expression of HLA-F using a specific Ab raised against a synthetic peptide corresponding to amino acids 61-84 in the alpha1 domain of the predicted HLA-F protein. HLA-F is expressed as a beta2-microglobulin-associated, 42-kDa protein that shows a restricted tissue distribution. To date, we have detected this product only in peripheral blood B cells, B cell lines, and tissues containing B cells, in particular adult tonsil and fetal liver, a major site of B cell development. Thermostability assays suggest that HLA-F is expressed as an empty heterodimer devoid of peptide. Consistent with this, studies using endoglycosidase-H and cell surface immunoprecipitations also indicate that the overwhelming majority of HLA-F contains an immature oligosaccharide component and is expressed inside the cell. We have found that IFN-gamma treatment induces expression of HLA-F mRNA and HLA-F protein, but that this does not result in concomitant cell surface expression. HLA-F associates with at least two components of the conventional class I assembly pathway, calreticulin and TAP. The unusual characteristics of the predicted peptide-binding groove together with the predominantly intracellular localization raise the possibility that HLA-F may be capable of binding only a restricted set of peptides.

Expression of CD1D mRNA transcripts in human choriocarcinoma cell lines and placentally derived trophoblast cells.

Human placental trophoblast is critically involved in mediating maternal tolerance of the fetal semiallograft. Genes encoding highly polymorphic major histocompatibility complex (MHC) class I and class II antigens that could provoke maternal immune rejection responses are silenced in trophoblast. However, several MHC class I or class I-related products exhibiting reduced or negligible polymorphism are expressed and assumed to be functionally involved in maintaining pregnancy. The CD1 gene family encodes non-polymorphic MHC class I-like products that have the unusual ability to present non-peptide antigens to T cells. One member, CD1D, is expressed in certain epithelial cells and interacts with a specific T-cell subset that may promote the development of Th2-mediated responses believed to be associated with pregnancy. In this study we examined the expression of CD1D in human trophoblast cell lines and placentally derived trophoblast cells by reverse transcriptase-polymerase chain reaction using CD1D-specific oligonucleotide primers. We have found that CD1D mRNA transcripts are expressed in trophoblast cells and cell lines. We have also identified a novel alternatively spliced CD1D mRNA transcript lacking exon 4. Exon 4-intact and exon 4-deficient CD1D transcripts appear to be differentially expressed in different trophoblast and non-trophoblast cell populations. Our studies suggest that at least one member of the CD1 family is transcribed in human trophoblast.

Calreticulin associates with non-HLA-A,-B class I proteins in the human choriocarcinoma cell lines JEG-3 and BeWo.

Human placental trophoblast expresses as unusual repertoire of major histocompatibility complex (MHC) class I products that appears to reflect the unique role of this epithelium in mediating feto-maternal relations during pregnancy. Trophoblast is devoid of human leucocyte antigen (HLA)-A,-B antigens but can express one or more non-HLA-A,-B class I proteins. The human choriocarcinoma cell lines JEG-3, BeWo and JAR are widely used as models to study trophoblast. During attempts to isolate non-HLA-A,-B class I from JEG-3 and BeWo by immunoaffinity chromatography using a monoclonal antibody to beta 2-microglobulin we observed a 55,000 MW protein co-purifying with class I. N-terminal amino acid sequencing and immunoblotting using a specific antiserum identified this product as calreticulin, a molecule recently shown to be involved in the assembly of classical class I in human B-lymphoblastoid cells. In our hands JEG-3 and BeWo were found to express 45,000 MW non-HLA-A,-B class I proteins while the 40,000 MW HLA-G product was identified only in JEG-3. Our data suggest that calreticulin associates with non-HLA-A,-B class I heterodimers and with free 45,000 MW non-HLA-A,-B class I H chains in JEG-3. JAR was found to be devoid of detectable class I H chains but contained beta 2-microglobulin and calreticulin. However, calreticulin-beta 2-microglobulin complexes were not detected in JAR. Calreticulin and class I were apparently co-localized within the endoplasmic reticulum of JEG-3 cells whereas only class I was expressed at the cell surface. These studies demonstrate that calreticulin is associated with non-HLA-A,-B class I products in human choriocarcinoma cells.

Distribution of Fc gamma receptors on trophoblast during human placental development: an immunohistochemical and immunoblotting study.

Expression of Fc gamma receptors on human placental trophoblast was investigated by immunostaining and immunoblotting using a panel of Fc gamma receptor monoclonal antibodies (mAb). Fc gamma receptors typical of other cell types were not detected on syncytiotrophoblast in term placentae when transplacental IgG transport was maximal. Unexpectedly, however, and by contrast with term, all Fc gamma receptor III mAb tested bound to first trimester placental syncytiotrophoblast by immunostaining. Reactivity was relatively restricted and varied between specimens. Fc gamma receptor III products of 41,000-45,000 and 49,000-52,000 MW were consistently detected on first trimester trophoblast membranes by immunoblotting and levels of these products were greatly reduced following treatment with phosphatidylinositol-specific phospholipase C, suggesting that the early trophoblast Fc gamma receptor III is glycosyl-phosphatidylinositol (GPI) linked. The mAb Leu-11b behaved differently to other anti-Fc gamma receptor III mAb examined. By immunostaining, Leu-11b bound to syncytiotrophoblast at term and detected both syncytiotrophoblast and underlying cytotrophoblast in the first trimester. In addition to the GPI-anchored Fc gamma receptor III in first trimester, Leu-11b also detected a 74,000 MW component on both first trimester and term trophoblast membranes by immunoblotting. Thus trophoblast appears to express a GPI-anchored Fc gamma receptor III in first trimester but not term placentae. With the exception of the 74,000 MW Leu-11b-defined product whose function is unclear, currently available Fc gamma receptor mAb appear to be incapable of detecting the protein involved in IgG transport during the later stages of gestation.

A phase-dependent delay of the chick pineal rhythm in rate of thymidine incorporation by brief exposure to aphidicolin.

Cultured chick pineal glands show a persistent rhythm in the rate of cumulative incorporation of thymidine into DNA. In this study we have examined the effects of pulse-exposure to aphidicolin in the dark on the first day of culture on thymidine incorporation during the second and third days of culture in the dark with aphidicolin-free medium. The phase of the rhythm in the rate of thymidine incorporation was delayed in a concentration-dependent manner by a 4-hr exposure to aphidicolin, commencing in the final hour of the photoperiod. This effect was phase-dependent and not seen when exposure to aphidicolin began earlier in the photoperiod.

A phase-dependent delay of the chick pineal rhythm in rate of thymidine incorporation by brief exposure to ouabain.

Cultured chick pineal glands show a persistent rhythm in the rate of cumulative incorporation of thymidine into DNA [Wainwright and Wainwright, 1989]. In this study we have examined the effects of a pulse-exposure to ouabain in the dark on the first day of culture upon thymidine incorporation during the second and third days of culture in the dark with ouabain-free medium. The phase of the rhythm in rate of thymidine incorporation was delayed by a 4-hr exposure to 100 microM ouabain commencing in the final hour of the photoperiod, but not by a 2-hr exposure or by 10 microM ouabain. This effect was phase-dependent and not seen when exposure to ouabain began earlier in the photoperiod. The phase delay caused by ouabain was not due to a persistent direct inhibition of the process of thymidine incorporation. The phase-shift due to exposure to ouabain was superimposed on a phase delay caused by renewal of culture medium 4 hr after explanting the glands into culture.

Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).

The complement (C) regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46), which control C3 convertases, together with CD59, an inhibitor of the membrane attack complex (MAC), were found to be present in the developing human placenta from at least 6 weeks of gestation until term. Immunostaining revealed differences in the distribution of these proteins on the fetally derived trophoblast epithelium, especially in early placentae which contain trophoblast populations of diverse proliferative potential and differentiation status. Expression of all three proteins occurred on the terminally differentiated syncytiotrophoblast epithelium covering chorionic villi and which is in direct contact with maternal blood. CD59 was also expressed on the underlying villous cytotrophoblast cells and on their extra-villous derivatives. These two populations showed differential expression of the C3 convertase regulators. Villous cytotrophoblast cells expressed MCP but were largely devoid of DAF. Proliferation of this population to generate extra-villous cytotrophoblast cell columns was associated with both an increase in DAF expression and a decrease in MCP expression. Throughout placental development, expression of DAF appeared to be lower than that of MCP and CD59 as assessed by solid-phase binding assays on isolated trophoblast membranes. Early placentae were also found to contain both DAF+ and DAF- chorionic villi. Conversely, expression of CD59 appeared comparatively high and transcripts for CD59 were found to be much more abundant than those for DAF in purified trophoblast cells. C regulatory proteins appear to play an important role throughout gestation in protecting the fetally derived human conceptus from maternal C. The differential expression patterns of the proteins on trophoblast may reflect differences in requirement for specific functional activities at different locations within the placenta.

Inhibition of the chick pineal rhythm in rate of thymidine incorporation by cyclic AMP.

Chick pineal glands in organ culture showed a circadian rhythm in the rate of thymidine incorporation. Thymidine incorporation was very markedly inhibited when 3-isobutyl-l-methylxanthine (IBMX) was continuously present. When IBMX was added to cultures in control medium during the photoperiod of the second day in culture, the extent of inhibition of incorporation during that photoperiod increased with the increase in length of the photoperiod remaining. Incorporation did not resume at the start of a second photoperiod if IBMX was added within the first 10 h of the first photoperiod. Corresponding results were obtained with glands continuously cultured in constant darkness. Similar results were also obtained using glands treated with 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (Ro 20-1724), 7 beta-acetoxy-8,13-epoxy-1 alpha, 6 beta, 9 alpha-trihydroxy-1abd-14-ene-11-one (forskolin), or 8-bromo-cyclic AMP, but not with 8-bromo-cyclic GMP. When glands cultured with IBMX were transferred to control medium, incorporation remained inhibited until the start of the next photoperiod. We conclude that the increase in the rate of thymidine incorporation at the start of each new photoperiod is dependent on a "switch" process that is inhibited by elevated concentrations of cyclic AMP.

Thymidine kinase activity of the chick pineal gland.

Pineal thymidine kinase activity of 1-week-old chicks in situ varied significantly throughout the day. However, the circadian rhythm of thymidine incorporation seen with cultured chick pineal glands was not accompanied by variations in level of thymidine kinase activity in vitro. Thus the circadian rhythm in rate of cumulative incorporation of thymidine by cultured chick pineal glands is not determined by a rhythm in rate of the first reaction of the complex series of reactions by which thymidine is incorporated into DNA.

Purinergic receptors have no major role in control of the circadian rhythm in rate of thymidine incorporation by cultured chick pineal glands.

We have examined the effects of some analogues of adenosine upon the circadian rhythm in rate of thymidine incorporation by cultured chick pineal glands. Incorporation in the early period of the photoperiod on day 2 of culture was slightly inhibited by the adenosine analogue N-ethylcarboxamido-adenosine, but this effect was not countered by the antagonist 8-phenyl-theophylline. Thymidine incorporation was inhibited when glands were continuously exposed to the adenosine transport inhibitor nitrobenzyl-thioinosine, but ongoing incorporation was not inhibited by addition of this agent. Removal of adenosine and deoxyadenosine supplements from the medium, with or without further addition of adenosine deaminase, had no appreciable effects upon thymidine incorporation. We conclude that adenosine and analogues probably play no role in regulation of the rhythm in rate of thymidine incorporation.

The membrane domain of the human erythrocyte anion transport protein. Epitope mapping of a monoclonal antibody defines the location of a cytoplasmic loop near the C-terminus of the protein.

We have used synthetic peptides to study the location of the amino acid sequences in the human erythrocyte anion transport protein (band 3) which are recognized by four murine monoclonal antibodies, BRIC 130, 132, 154 and 155. These antibodies are known to react with epitopes in the protein which are on the cytoplasmic side of the membrane. The results suggest that the amino acid residues important for the reaction of BRIC 130 and BRIC 154/155 are located within amino acids 899-908 and 895-901 respectively in the cytoplasmic tail of the protein. The BRIC 132 epitope is located within amino acid residues 813-824. This is part of a surface loop in the protein which probably extends from residue 814 to residue 832 and is located on the cytoplasmic side of the membrane. These results provide direct evidence for the topographical location of a sequence in a poorly understood region of the protein.

Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy.

The expression of decay accelerating factor (DAF) was investigated in human fetal and extra-fetal tissues using a panel of mAb directed against different epitopes on the DAF molecule. By immunostaining, extensive reactivity was observed on the placental trophoblast epithelium and this was confined exclusively to sites of direct contact with maternal blood and tissues at the fetomaternal interface. Within the fetus, by contrast, very little staining was observed especially on hemopoietic cell populations in the developing liver. The antibodies identified a component of 70,000 m.w., comigrating on SDS-PAGE with red cell DAF, on isolated trophoblast membranes and an apparently quantitative increase in the expression of DAF was observed during placental development. Northern analysis using a DAF cDNA clone revealed 1.5-, 1.6-, and 2.2-kb mRNA transcripts typical of DAF in mRNA prepared from whole term placentae and from purified trophoblast cells. DAF appears to be preferentially expressed at the fetomaternal interface during development and may function specifically to inhibit amplification convertases formed at this site either directly or indirectly as a result of maternal complement activation. This molecule may play an important role in protecting the semiallogeneic human conceptus from maternal C-mediated attack.

Thymidine incorporation by chick pineal glands as studied by pulse-labelling in vitro.

We have studied the pattern of variations in extent of thymidine incorporation during pulse-labelling in cultured chick pineal glands. During the first 24-30 h in culture the extent of pulse-labelling varied in parallel with the cycle in cumulative incorporation. Pulse-labelling was seen during the period of apparent arrest of cumulative incorporation. However, it was probably "masked" by the SD of assays of cumulative incorporation and represented a minor, but distinct, process of thymidine incorporation. The pattern of variation in extent of pulse-labelling was qualitatively consistent under a wide variety of conditions. Control of this pattern appeared to be different from that of the circadian rhythm in cumulative thymidine incorporation.

Entrainment of the rhythm in thymidine incorporation by cultured chick pineal glands.

Young chicks were raised under a standard cycle of illumination and their pineal glands were cultured in organ culture. We have already reported a rhythmic daily cycle in the cumulative incorporation of thymidine into DNA when the glands were incubated under the cycle of illumination to which they were entrained in vivo. Incorporation ceased shortly after the end of the photoperiod and resumed again at, or shortly after, start of the following photoperiod. We have now shown that this cycle was entrained to other lighting schedules and largely unaffected by the time of explanting into culture. The rhythm also persisted in glands cultured in constant darkness. However, when the cycle was maintained by daily renewal of the culture medium it was markedly affected by changes in the time of day at which medium was renewed. Results for glands cultured under constant illumination were inconsistent.

Thymidine incorporation by cultured chick pineal glands is not subject to adrenergic regulation.

Norepinephrine is known to play a role in regulating the circadian rhythms of serotonin N-acetyltransferase activity and melatonin formation in the chick pineal gland. We have recently demonstrated that the cultured chick pineal exhibits a circadian rhythm in the incorporation of thymidine. In this study we show that this latter rhythm is not subject to adrenergic control.

Monoclonal antibodies to the membrane domain of the human erythrocyte anion transport protein. Localization of the C-terminus of the protein to the cytoplasmic side of the red cell membrane and distribution of the protein in some human tissues.

(1) We have prepared murine monoclonal antibodies to the membrane domain of the human erythrocyte anion transport protein (band 3). (2) All of these antibodies react with regions of the protein located at the cytoplasmic surface of the red cell. (3) One of the antibodies reacts with an epitope present on a cytoplasmic loop of the protein located between the C-terminus and a point 168 amino acids from the C-terminus. The other antibodies recognize different epitopes on the C-terminal tail of the protein and the sequences likely to be involved in these epitopes are defined. (4) Our results show that the C-terminus of the red-cell anion transport protein is located on the cytoplasmic side of the red-cell membrane. (5) None of the antibodies inhibited sulphate exchange transport when introduced into resealed red-cell membranes; however, the bivalent form of one of the antibodies reduced the inhibitory potency of 4-acetamido-4'-isothiocyanatostilbene disulphonate on sulphate exchange transport in resealed erythrocyte membranes. (6) Immunostaining of human kidney sections with the antibodies showed strong staining of the basolateral membrane of some but not all of the epithelial cells of distal tubules and the initial connecting segment of collecting tubules. With human liver, only the haematopoeitic cells of fetal liver reacted with all the antibodies.

Rhythmic incorporation of thymidine by chick pineal glands in vitro.

Cultured chick pineal glands showed a cycle in the cumulative incorporation of thymidine into DNA. In undisturbed cultures the rate of thymidine incorporation, amount of thymidine incorporated per 1-day cycle, and persistence of the incorporation process were all markedly affected by the concentration of exogenous precursor. However, more than two full cycles of incorporation were found when culture medium of low thymidine content was renewed daily, or when medium of intermediate concentration was replaced on the 3rd day of culture. At a high thymidine concentration the second cycle of incorporation sometimes appeared to be impaired. At all concentrations tested, less than 2% of the available thymidine was incorporated.

On the uptake and incorporation of thymidine by cultured chick pineal glands.

Cultured chick pineal glands showed a marked cycle in the incorporation of thymidine into DNA. They also accumulated exogenous thymidine in one, or more, endogenous thymidine pool(s). However, there was no significant variation in ability to take up thymidine during incubation with either standard medium or media of increased thymidine content. We could not eliminate the possibility of variation in size of a quantitatively minor, but metabolically extremely important, thymidine pool which "channels" precursor directly into DNA.

On thymidine incorporation by the cultured chick pineal gland.

Explanted chick pineal glands exhibited a cycle in thymidine incorporation when cultured either under a cycle of illumination or in constant darkness. This cycle appeared to be entrained to the light cycle under which the birds were maintained. The incorporation reflected gene replication in a small fraction of the cell population that was largely, but not entirely, located in the stroma of the gland. Glands cultured with colchicine for 28 h contained a very small number of cells showing metaphase chromosomes.